首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 125 毫秒
1.
中风病是一种临床常见病,由于颅内出血或血脉梗死致使脑部组织缺血缺氧,是造成中风病后出现言语不利甚至失语的原因。中风病后出现言语不利、失语,能自然恢复者较少,治疗上颇多困难。采用补阳还五汤为主加减,结合体针、头针等治疗中风后言语不利109例,取得明显疗效。现报道如下。  相似文献   

2.
中医辨证分型治疗中风后抑郁症36例   总被引:1,自引:0,他引:1  
中风后抑郁症是中风后较常见的心理障碍性疾病,发病率高,病程长。该病处理不当,将会影响中风病人神经功能的康复,给病人的预后带来严重影响。临床根据中医辨证,给予辨证分型治疗,收到了良好的治疗效果,现报道如下。  相似文献   

3.
一提起中风,许多老人家都有一种谈虎色变的感觉,一旦发生中风.轻则令人言语不利,口眼歪斜;重则不能言语,半身不遂,瘫卧床上,生活起居都要人照顾:病情凶险者还会死亡。所以了解中风的发病和预防.无论对社会和家庭都有重要意义。  相似文献   

4.
左右辨证治疗中风偏瘫   总被引:2,自引:1,他引:1  
目的 探讨从左右辨证入手治疗中风偏瘫的临床疗效。方法 用左瘫汤及右瘫汤,左右辨证,治疗中风偏瘫共103例,并随机设立传统辨证施治作对照。结果 治疗组愈显率为84.5%,明显优于对照组的61.9%(P〈0.05);治疗组治疗后神经功能缺损评分及Barthel指数均明显优于对照组(P〈0.05)。结论 左右辨证治疗中风偏瘫,可明显改善病人的临床疗效。  相似文献   

5.
目的中风后呃逆是临床神经内科常见并发症,通过分析文献,总结中风后呃逆的病机,为中医辨证治疗提供指导。  相似文献   

6.
电针配合中药治疗中风后遗症   总被引:1,自引:0,他引:1  
中风又名“卒中”,是以猝然昏倒、不省人事或口眼歪斜、语言不利、半身不遂为主要特征的病征,中风病人常留有不同程度的后遗症,如半身不遂、言语不利,甚至不能自理。笔者采用电针及电针配合中药治疗中风后遗症3 60例,取得较满意的疗效。1 资料与方法1.1 临床资料 中风后遗症3 60例,男性2 0 9例,女性15 1例,其中年龄最小的2 3岁,最大的78岁,病程6个月2 3 2例,7个月至1年110例,1年以上18例,随机分成单纯性电针治疗组(电针组)和电针配合中药治疗组(针药组) ,电针组10 2例,针药组2 5 8例,两组性别、年龄、病程均无明显差异。1.2 方法1.2 .1…  相似文献   

7.
目的观察针刺结合中医辨证施护中风抑郁患者护理干预的效果。方法选择我院60例中风后抑郁患者,随机分为观察组和对照组各30例,观察组给予针刺治疗,并根据辨证分型给予相应护理。对照组给予针刺治疗,并给予常规护理。4用为1个疗程,观察治疗后两组患者的HAMD评分和Fugl—Meyer运动功能评分、改良Barthel指数评分。结果观察组治疗后改良Bathel指数评分、Fugl-Meyer运动功能评分高于对照组,差异均有统计学意义(P〈0.01);观察组治疗后HAMD评分低于对照组,差异有统计学意义(P〈0.01)。结论针刺结合中医辨证施护中风后抑郁患者的护理干预能有效提高患者的生活质量。  相似文献   

8.
中风又名“卒中” ,是临床上常见病、多发病之一 ,死亡率和致残率都较高。经过救治后 ,大部分患者都留有半身不遂、言语不利、口眼歪斜等后遗症。肢体运动功能障碍是中风后重要的临床表现。这不仅由于生活不能自理给患者带来痛苦 ,也给家庭和社会带来更大负担。如何能使瘫痪肢体恢复功能 ,十余年来我们以体针配合头针、推拿与按摩、康复锻炼等综合疗法为主 ,治疗中风肢体运动功能障碍 ,取得了满意的效果 ,现报道如下。1 临床资料   84例偏瘫患者 ,男 6 0例 ,女 2 4例 ;年龄最小 35岁 ,最大 78岁 ;病程紧短 6d ,最长 1年 ,3个月以内 2 9…  相似文献   

9.
中风是以突然昏倒、意识不清、口渴、言蹇、偏瘫为主症的一种疾病。它包括现代医学的脑出血、脑血栓、脑栓塞、短暂性脑缺血发作等病。中风后常遗有半身不遂、语言不利、口眼歪斜等后遗症。笔者应用中医药治疗38例,报告如下。  相似文献   

10.
目的观察三部开窍利咽针刺法配合辨证取穴治疗中风后吞咽困难的临床疗效。方法选取缺血性中风合并吞咽困难并洼田饮水试验评价Ⅲ级以上的病人83例,随机分为治疗组(42例)和对照组(41例)。两组基础治疗相同,均给予规范的内科药物治疗,治疗组在此基础上给予三部开窍利咽针刺法配合辨证取穴治疗,分别于治疗前、治疗2周后进行洼田饮水试验及吞咽障碍特异性生活质量量表(SWAL-QOL)、改良Barthel量表(MBI)评价。结果两组病人治疗后洼田饮水试验、SWAL-QOL、MBI评分均较治疗前明显改善(P0.05):治疗后两组各量表评分比较差异均具有统计学意义(P0.05),且治疗组各项指标改善程度均明显优于对照组(P0.05)。三部开窍利咽针刺法配合辨证取穴治疗中风后吞咽困难的总有效率达95.24%,显效率69.05%,治疗组明显优于对照组,两组比较差异有统计学意义(P0.05)。结论三部开窍利咽针刺法配合辨证取穴治疗有助于改善中风后假性延髓性麻痹所致吞咽困难。  相似文献   

11.
Theory of traditional Chinese medicine and therapeutic method of diseases   总被引:6,自引:0,他引:6  
Traditional Chinese medicine, including herbal medicine and acupuncture, as one of the most important parts in complementary and alternative medicine (CAM), plays the key role in the formation of integrative medicine. Why do not the modern drugs targeting the specificity of diseases produce theoretical effects in clinical observation? Why does not the traditional Chinese medicine targeting the Zheng (syndrome) produce theoretical effects in clinic? There should have some reasons to combine Western medicine with Chinese herbal medicine so as to form the integrative medicine. During the integration, how to clarify the impact of CAM theory on Western medicine has become an emergent topic. This paper focuses on the exploration of the impact of theory of traditional Chinese medicine on the therapy of diseases in Western medicine.  相似文献   

12.
Background:Acupuncture combined with Chinese herbal medicine has been widely utilized for pain management in patients with diabetic peripheral neuropathy (DPN). However, its results are still inconsistent, and no systematic review has specifically addressed this issue. Thus, this systematic review will comprehensively and systematically investigate the effectiveness and safety of acupuncture combined with Chinese herbal medicine for pain relief in DPN.Methods:Randomized controlled trials on acupuncture combined with Chinese herbal medicine treatment of DPN published before September of 2021 will be searched in 9 databases including Medline, Web of Science, PubMed, Cochrane Library, Excerpta Medica Database, Sinomed, China National Knowledge Infrastructure, WanFang, and China Science and Technology Journal Database. The methodological assessment performed using the risk of bias assessment tool of Cochrane, and the level of evidence quality for the main results will be evaluated by a recommended grading, evaluation, formulation, and evaluation system approach. Bayesian network meta-analysis will be conducted using STATA V.14.0 and WinBUGS V.1.4.3.Results:This study will provide a high-quality comprehensive evaluation of the safety of acupuncture combined with Chinese herbal medicine for treating DPN.Conclusion:This systematic review will evaluate the efficacy and safety of Chinese herbal medicine combined with acupuncture in the treatment of DPN, and provide the latest evidence for clinical application.Ethics and dissemination:The protocol of the systematic review does not require ethical approval because it does not involve humans. This article will be published in peer-reviewed journals and presented at relevant conferences.Registration number: INPLASY2021100004.  相似文献   

13.
Background:Coronary heart disease (CHD) angina pectoris is a clinical syndrome in which episodic chest pain or chest discomfort is the main manifestation of temporary ischemia and hypoxia of the myocardium due to coronary atherosclerosis and coronary artery functional changes (spasm). A large amount of clinical evidence confirms that acupuncture combined with Chinese herbal medicine in the treatment of CHD and angina pectoris can relieve the symptoms of angina pectoris and improve the performance of electrocardiograph ischemia; It still has obvious therapeutic effects in regulating the levels of cardiovascular regulatory peptides ET and cGRP. To better evaluate the effectiveness and safety of acupuncture combined with Chinese herbal medicine in the treatment of CHD and angina pectoris, we designed a systematic evaluation program to provide a reliable scientific basis for the future use of this method.Methods:Search Pubmed database, Embase, Cochrane library, Chinese Biomedical Literature CD-ROM Database (CBMdisk), China Journal Network Full-text Database (CNKI), Wanfang Database, Web of Science (SCI-E), the retrieval time is established from each database Until October 2021, search for relevant eligible randomized controlled trials with keywords or subject terms “acupuncture”, “Chinese herbal medicine”, and “CHD angina”. Outcome indicators were clinical symptoms of CHD and angina pectoris, changes in electrocardiogram, changes in blood lipids, and significant improvement in traditional Chinese medicine syndromes before and after treatment. Two researchers independently carried out data extraction and quality assessment, and use RevMan5.3 software to carry out final data analysis and assessment.Results:This study provides a reliable clinical scientific basis for acupuncture combined with Chinese herbal medicine for the treatment of CHD and angina pectoris.Conclusion:Acupuncture combined with Chinese herbal medicine can effectively relieve the clinical symptoms of CHD and angina pectoris and improve the performance of electrocardiograph. At the same time, it can reduce the cardiovascular regulatory peptide ET and increase the level of cGRP in the patient''s plasma, thus confirming its effectiveness and safety.  相似文献   

14.
Background:Primary liver cancer (PLC) is a common cancer, and its morbidity and mortality are ranked 6th and 3rd in the world for malignant tumors, respectively. And this number is still on the rise, seriously endangering people''s health. In recent years, acupuncture combined with Chinese herbal medicine have been widely used in the treatment of PLC, and there are few restrictions. However, we have not found a meta-analysis of their synergistic effects. Therefore, this systematic review and meta-analysis will evaluate the efficacy and acupuncture combined with Chinese herbal medicine in the treatment of primary liver cancer.Method:We will search the following databases from inception up to August 20, 2021: PubMed, Web of Science, Embase, AMED, Cochrane Library, CNKI, VIP, CBM, and Wanfang. There will be no restrictions regarding publication date or language. We will apply a combination of medical keywords and words, including “acupuncture,” “Chinese herbal medicine” and “primary liver cancer”. Additionally, we will manually search all reference lists from relevant systematic reviews to find other eligible studies. We will use the random effects model in REVMAN v5.3 for meta-analysis. The study for acupuncture combined with Chinese herbal medicine in the treatment of PLC was a randomized controlled study. Two researchers will independently review the research selection, data extraction, and research quality assessments. Finally, we will observe the outcome measures.Results:This study will provide evidence-based medical evidence for the treatment of PLC with a combination of acupuncture and Chinese herbal medicine, and provide new ideas and methods for the treatment of PLC.Registration number: INPLASY202180103  相似文献   

15.
动物模型是药物研发和疫苗评价的重要平台,对于抗艾滋病药物和疫苗研究也是不可或缺的。在中医药抗艾滋病研究中,动物模型发挥着重要的作用。但是目前所用动物模型主要为常用的猴免疫缺陷病毒(SIV)感染的猴模型,由于缺少中医特色,对于评价中医药的疗效尚有不足之处。文章简要介绍了灵长类动物艾滋病(AIDS)模型在中医药防治艾滋病研究领域的应用情况,并对目前存在的问题和未来努力的方向进行了探讨。  相似文献   

16.
The objective of this cross-sectional study was to assess the use of traditional herbal medicine by AIDS patients in Kabarole District, western Uganda. Using systematic sampling, 137 AIDS patients were selected from outpatient departments of 3 hospitals and interviewed via questionnaire. The questions related to such areas as type and frequency of herbal medicine intake, concomitant herb-pharmaceutical drug use (including herb-antiretroviral drug cotherapy), and the perceived effectiveness of herbal medicine. Overall, 63.5% of AIDS patients had used herbal medicine after HIV diagnosis. Same-day herbal medicine and pharmaceutical drugs use was reported by 32.8% of AIDS patients. Patterns of traditional herbal medicine use were quite similar between those on antiretroviral therapy and those who received supportive therapy only. The primary conclusion is that AIDS outpatients commonly use herbal medicine for the treatment of HIV/AIDS. Pharmacological interactions between antiretroviral drugs and traditional herbal medicines need to be further examined.  相似文献   

17.
Cardiovascular diseases, the number one causes of death worldwide, are responsible for the majority of the increased morbidity and mortality seen in patients with diabetes mellitus. Useful therapies for diabetes include lifestyle modification and drugs to lower conventional cardiovascular risk factors, such as metformin, thiazolindinedione, sulfonylureas and evidence-based drugs. These hypoglycemic or antihyperglycemic agents are widely used either for monotherapy or in combination to improve glycemic control and to slow disease progression associated with a decline in pancreatic function in diabetic patients. In addition, a large body of clinical evidence has suggested that the appropriate use of traditional Chinese medicines with modern Western medicinal, or mainstream antidiabetic drugs, can prevent or ameliorate the development of diabetic complications. The traditional Chinese medicine diagnostics are based on "zheng" or "symptom", a system emphasizing the overall function of the human body. Since diabetes is a rather complicated metabolic disorder involving multi-organ damage, a majority of diabetic patients may be subject to multi-pharmacy to combat symptoms resulting from diabetes. Many diabetic patients choose alternative therapeutic approaches such as herbal or traditional Chinese medicine along with the mainstream anti-diabetic drugs, thus making alternative therapy for diabetes a popular remedy. In this review, we will briefly summarize the application of herbal or traditional Chinese medicinal therapy for diabetes with an emphasis on diabetic cardiovascular complications.  相似文献   

18.
Background:Diabetic nephropathy (DN) is one of the most serious complications in the development of diabetes mellitus, which has become the main cause of end-stage renal disease and one of the main causes of death in diabetic patients. With the prevalence of diabetes, the number of patients at risk for developing DN is increasing, with 20–40 percent of all patients with diabetes at risk for developing DN. Acupuncture and Chinese herbal medicine treatments are often combined to treat DN; however, there has been no meta-analysis on their synergistic effects. Therefore, we aimed to perform a systematic review and meta-analysis to estimate the effectiveness of acupuncture combined with Chinese herbal medicine for DN treatment.Methods:Nine electronic databases were retrieved for this study. The English databases mainly retrieved PubMed, Web of Science, Embase, AMED, and the Cochrane Library, while the CNKI, VIP, CBM, and Wanfang databases were used to retrieve the Chinese literature. There is no definite time limit for the retrieval literature, and the languages are limited to Chinese and English. We will consider articles published between database initiation and August 2021. We used Review Manager 5.4, provided by the Cochrane Collaborative Network for statistical analysis. Clinical randomized controlled trials related to acupuncture combined with Chinese herbal medicine for DN were included in this study. Research selection, data extraction, and research quality assessments were independently completed by two researchers. We then assessed the quality and risk of the included studies and observed the outcome measures.Results:This study provides a high-quality synthesis to assess the effectiveness and safety of acupuncture combined with Chinese herbal medicine for treating DN.Conclusion:This systematic review will provide evidence to determine whether acupuncture combined with Chinese herbal medicine is an effective and safe intervention for patients with DN.Ethics and dissemination:The protocol of the systematic review does not require ethical approval because it does not involve humans. This article will be published in peer-reviewed journals and presented at relevant conferences.Registration number:INPLASY202180018  相似文献   

19.
Background:Research into acupuncture and moxibustion and their application for chronic fatigue syndrome (CFS) has been growing, but the findings have been inconsistent.Objective:To evaluate the existing randomized clinical trials (RCTs), compare the efficacy of acupuncture, moxibustion and other traditional Chinese medicine (TCM) treatments.Data sources:Three English-language databases (PubMed, Embase, Web of Science, and The Cochrane Library) and 4 Chinese-language biomedical databases (Chinese Biomedical Literature Database, VIP Database for Chinese Technical Periodicals, China National Knowledge Infrastructure, and Wanfang) were searched for RCTs published from database inception through August 2021.Study selection:RCTs include acupuncture, moxibustion, traditional Chinese herbal medicine, western medicine and no control.Data extraction and synthesis:Data were screened and extracted independently using predesigned forms. The quality of RCTs was appraised with the Cochrane Collaboration risk of bias tool. We conducted a random-effects network meta-analysis within a frequentist framework. We assessed the certainty of evidence contributing to network estimates of the main outcomes with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework.Main outcomes and measures:The primary outcomes were the overall response rate and FS-14 scale.Results:A total of 51 randomized controlled trials involving 3473 patients with CFS were included in this review. Forty one studies indicate low risk or unknown risk, and the GRADE scores of the combined results show low levels. Among the main indicators, traditional Chinese medicine therapies have excellent performance. However, the overall response rate is slightly different from the results obtained from the Fatigue Scale-14 total score. Moxibustion and traditional Chinese medicine (Odds ratios 48, 95% CrI 15–150) perform better in the total effective rate, while moxibustion plus acupuncture (MD 4.5, 95% CrI 3.0–5.9) is better in the FS-14 total score.Conclusions:The effect of acupuncture and moxibustion in the treatment of CFS was significantly higher than that of other treatments. Traditional Chinese medicine should be used more widely in the treatment of CFS.  相似文献   

20.
Background:Diabetes has become a global public health problem and danger to human health. Diabetes is the main cause of blindness, kidney failure, heart attack, stroke, and lower limb amputation. According to the latest epidemiological survey and research, the overall prevalence of diabetes in mainland China is 11.2%, of which type 2 diabetes mellitus (T2DM) accounts for more than 90% acupuncture combined with Chinese herbal medicine have been widely used in the treatment of T2DM. However, we have not found a meta-analysis of their synergistic effects. Therefore, this systematic review and meta-analysis aims to evaluate the efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of T2DM.Method:From inception up to September 20, 2021, the PubMed, Web of Science, Embase, AMED, Cochrane Library, CNKI, VIP, CBM, and Wanfang databases will be searched. The publication date or language will not be limited. We will apply a combination of medical keywords, including “acupuncture”, “Chinese herbal medicine”, and “type 2 diabetes mellitus”. We will also check other ongoing and unpublished studies in the clinical trial registry. At the same time, we will manually search all reference lists from relevant systematic reviews to find other eligible studies. We will use Review Manager software (REVMAN v5.3 Cochrane Collaboration) to meta-analyze the selected literature. The study for acupuncture combined with Chinese herbal medicine in the treatment of T2DM was a randomized controlled study. Two researchers will independently review the research selection, data extraction, and research quality assessments. Finally, we will observe the outcome measures.Results:This study will generate evidence-based data on the treatment of T2DM with acupuncture combined with Chinese herbal medicine and will provide new ideas and treatment modalities to investigate in future research.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号